INS and disease of the tendon: The metabolic findings align with broader literature on diabetes and tendinopathy risk, with Cannata et al. (2020) [6] providing mechanistic insights into how chronic hyperglycemia, advanced glycation end products, and insulin resistance impair tendon tissue homeostasis.